These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16405198)

  • 1. FilterWire distal embolic protection device for vein graft stenting: initial single-center experience.
    Kolansky DM; Shah AJ; Mannion T; Glaser R; Hirshfeld JW; Wilensky RL; Herrmann HC
    Clin Cardiol; 2005 Dec; 28(12):556-60. PubMed ID: 16405198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention.
    Popma JJ; Cox N; Hauptmann KE; Reifart N; Virmani R; Emira K; Murphy S; Gibson CM; Grube E
    Catheter Cardiovasc Interv; 2002 Oct; 57(2):125-34. PubMed ID: 12357506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of adverse events during saphenous vein graft intervention with distal embolic protection: a PRIDE substudy.
    Kirtane AJ; Heyman ER; Metzger C; Breall JA; Carrozza JP
    JACC Cardiovasc Interv; 2008 Apr; 1(2):186-91. PubMed ID: 19463299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial.
    Kereiakes DJ; Turco MA; Breall J; Farhat NZ; Feldman RL; McLaurin B; Popma JJ; Mauri L; Zimetbaum P; Massaro J; Cutlip DE;
    JACC Cardiovasc Interv; 2008 Jun; 1(3):248-57. PubMed ID: 19463308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: differential effects after randomization to occlusion or filter-based embolic protection.
    Jonas M; Stone GW; Mehran R; Hermiller J; Feldman R; Herrmann HC; Cox DA; Kuntz RE; Popma JJ; Rogers C;
    Eur Heart J; 2006 Apr; 27(8):920-8. PubMed ID: 16415300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: results from the FIRE trial.
    Halkin A; Masud AZ; Rogers C; Hermiller J; Feldman R; Hall P; Haber RH; Cambier PA; Caputo RP; Turco M; Kovach R; Brodie B; Herrmann HC; Kuntz RE; Popma JJ; Ramee S; Cox DA; Mehran R; Stone GW
    Am Heart J; 2006 Apr; 151(4):915.e1-7. PubMed ID: 16569562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distal filter protection during saphenous vein graft stenting: technical and clinical correlates of efficacy.
    Stone GW; Rogers C; Ramee S; White C; Kuntz RE; Popma JJ; George J; Almany S; Bailey S
    J Am Coll Cardiol; 2002 Nov; 40(10):1882-8. PubMed ID: 12446075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events and modes of failure related to the FilterWire EZ Embolic Protection System: Lessons learned from an analytic review of the FDA MAUDE database.
    Khalid N; Javed H; Rogers T; Hashim H; Shlofmitz E; Chen Y; Khan JM; Musallam A; Torguson R; Bernardo NL; Waksman R
    Catheter Cardiovasc Interv; 2019 Jul; 94(1):157-164. PubMed ID: 30985082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of Adjunct Delivery Techniques to Optimize Deployment Success of Distal Protection Filters During Vein Graft Intervention.
    Kaliyadan AG; Chawla H; Fischman DL; Ruggiero N; Gannon M; Walinsky P; Savage MP
    J Invasive Cardiol; 2017 Feb; 29(2):54-58. PubMed ID: 27974668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts.
    Stone GW; Rogers C; Hermiller J; Feldman R; Hall P; Haber R; Masud A; Cambier P; Caputo RP; Turco M; Kovach R; Brodie B; Herrmann HC; Kuntz RE; Popma JJ; Ramee S; Cox DA;
    Circulation; 2003 Aug; 108(5):548-53. PubMed ID: 12874191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphometric analysis of particulate debris extracted by four different embolic protection devices from coronary arteries, aortocoronary saphenous vein conduits, and carotid arteries.
    Quan VH; Huynh R; Seifert PA; Kuchela A; Chen WH; Sütsch G; Eisenhauer AC; Rogers C
    Am J Cardiol; 2005 Jun; 95(12):1415-9. PubMed ID: 15950562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of vessel diameter on the efficacy of distal protection devices during saphenous vein graft intervention.
    Swaminathan A; Stone GW; Rogers C; Hermiller J; Feldman R; Hall P; Haber R; Masud AR; Cambier P; Caputo RP; Cox DA; Mehran R; Herrmann HC
    Am J Cardiol; 2005 Mar; 95(5):651-4. PubMed ID: 15721112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stenting of saphenous vein grafts trial.
    Badhey N; Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Addo TA; Haagen D; Abdel-Karim AR; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger PB; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):263-9. PubMed ID: 20665875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of embolic protection devices in ostial saphenous vein graft lesions.
    Abdel-Karim AR; Papayannis AC; Mahmood A; Michael TT; Rangan BV; Makke L; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1120-6. PubMed ID: 22422709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts.
    Baim DS; Wahr D; George B; Leon MB; Greenberg J; Cutlip DE; Kaya U; Popma JJ; Ho KK; Kuntz RE;
    Circulation; 2002 Mar; 105(11):1285-90. PubMed ID: 11901037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective use of embolic protection devices during saphenous vein grafts interventions: a single-center experience.
    Lavi S; Ivanov J; Appleby CE; Seidelin PH; Mackie K; Schwartz L; Dzavík V
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):1037-44. PubMed ID: 20517966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distal filter protection during percutaneous coronary intervention in native coronary arteries and saphenous vein grafts in patients with acute coronary syndromes.
    Pasquetto G; Reimers B; Favero L; Saccà S; Cernetti C; Napodano M; Piccolo P; Pascotto P
    Ital Heart J; 2003 Sep; 4(9):614-9. PubMed ID: 14635379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous saphenous vein graft intervention with sequential embolic protection devices: complementing lesion anatomy with embolic protection device.
    Grow P; Rab ST
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):636-40. PubMed ID: 18942125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bifurcating saphenous vein aorto-coronary bypass graft lesions: treatment of left main equivalent using two Filterwire EX distal protection devices.
    Prosser VM; Bailey SR
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):236-40. PubMed ID: 16331663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting.
    Bhargava B; Kornowski R; Mehran R; Kent KM; Hong MK; Lansky AJ; Waksman R; Pichard AD; Satler LF; Leon MB
    J Am Coll Cardiol; 2000 Feb; 35(2):389-97. PubMed ID: 10676686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.